| 000 | 00902 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250514220629.0 | ||
| 264 | 0 | _c20050527 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1060-0280 | ||
| 024 | 7 |
_a10.1345/aph.1E365 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVilleneuve, Eric | |
| 245 | 0 | 0 |
_aGlycoprotein IIb/IIIa inhibitors in patients with end-stage renal disease. _h[electronic resource] |
| 260 |
_bThe Annals of pharmacotherapy _cApr 2005 |
||
| 300 |
_a732-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 700 | 1 | _aSunderji, Rubina | |
| 773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 39 _gno. 4 _gp. 732-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1345/aph.1E365 _zAvailable from publisher's website |
| 999 |
_c15403136 _d15403136 |
||